OUR FUTURE IN LATIN AMERICA
Latin America and Mexico are one of the fastest-growing regions in the world with over 600 million people. Cardiovascular diseases are the leading cause of death in Latin America, with ischemic heart disease as the principal cause in most countries. Risk factors for cardiovascular disease are highly prevalent in the region. Overweight and obesity are increasing. In the 2012 Mexican National Survey, overweight or obesity was found in 64.9% of men and 73% of women, and they were strongly associated with sedentarism. The most characteristic dyslipidemia abnormality in the region is low high-density lipoprotein cholesterol, followed by elevated low-density lipoprotein cholesterol and increased levels of triglycerides. National diabetes mellitus prevalence ranges from 2.8% to 9.4% and tobacco smoking from 12.8% to 42%. (4)
medical tourism
If we are able to obtain regulatory approval in Mexico to treat disorders such as Parkinson's Disease, Multiple Sclerosis, Chronic Stroke, and "no option" heart disease, we believe that possibly millions of patients will travel to Mexico to be treated.
your are invited to attend
Heart Disease, Stroke, Peripheral Artery Disease, and Parkinson's Disease: Is "Therapeutic Angiogenesis" A Revolutionary Medical Breakthrough to Treat These Diseases?
You are invited to attend this free webinar on Wednesday, March 24, 2021
Please click the image on the left to link you to the webinar registration.